Please use this identifier to cite or link to this item:
|Title:||Early onset methotrexate-induced pancytopenia and response to G-CSF: A report of two cases|
|Authors:||Yoon, K.H. |
Granulocyte colony-stimulating factor
|Source:||Yoon, K.H., Ng, S.C. (2001). Early onset methotrexate-induced pancytopenia and response to G-CSF: A report of two cases. Journal of Clinical Rheumatology 7 (1) : 17-20. ScholarBank@NUS Repository.|
|Abstract:||Methotrexate (MTX) is one of the most widely used antirheumatic drugs for the treatment of rheumatoid arthritis. Whereas the hepatotoxicity of methotrexate is well recognized, the hematologic toxicity, namely, pancytopenia, is still a concern and is potentially fatal. We report two cases of early-onset methotrexate-induced pancytopenia that were successfully treated with granulocyte colony-stimulating factor (G-CSF). The pancytopenia improved with 3 days of administration. A review of the literature revealed at least 146 reported cases of MTX-induced pancytopenia. Significant risk factors for myelotoxicity included renal impairment, infection, and hypoalbuminemia. Successful management includes prompt discontinuation of MTX, intravenous folinic acid, high-dose steroids and, as in our case, G-CSF.|
|Source Title:||Journal of Clinical Rheumatology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 14, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.